CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' (DEFICIT) EQUITY - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning of the year at Dec. 31, 2018	$ 36,223	$ 56,303,061	$ (51,787,947)	$ 4,551,337
Balance at the beginning of the year (in Shares) at Dec. 31, 2018	36,222,752
Stock options granted to employees and consultants		2,190,293		2,190,293
Common stock issued upon exercise of stock options	$ 75	56,550		56,625
Common stock issued upon exercise of stock options (in shares)	75,000
Sale of common stock, net of issuance costs	$ 3,000	503,614		506,614
Sale of common stock, net of issuance costs (in shares)	3,000,000
Common stock issued for property and equipment	$ 5	7,995		8,000
Common stock issued for property and equipment (in shares)	5,000
Net loss			(7,408,497)	(7,408,497)
Balance at the end of the year at Jun. 30, 2019	$ 39,303	59,061,513	(59,196,444)	(95,628)
Balance at the end of the year(in Shares) at Jun. 30, 2019	39,302,752
Balance at the beginning of the year at Mar. 31, 2019	$ 36,223	57,774,054	(56,301,642)	1,508,635
Balance at the beginning of the year (in Shares) at Mar. 31, 2019	36,222,752
Stock options granted to employees and consultants		719,300		719,300
Common stock issued upon exercise of stock options	$ 75	56,550		56,625
Common stock issued upon exercise of stock options (in shares)	75,000
Sale of common stock, net of issuance costs	$ 3,000	503,614		506,614
Sale of common stock, net of issuance costs (in shares)	3,000,000
Common stock issued for property and equipment	$ 5	7,995		8,000
Common stock issued for property and equipment (in shares)	5,000
Net loss			(2,894,802)	(2,894,802)
Balance at the end of the year at Jun. 30, 2019	$ 39,303	59,061,513	(59,196,444)	(95,628)
Balance at the end of the year(in Shares) at Jun. 30, 2019	39,302,752
Balance at the beginning of the year at Dec. 31, 2019	$ 39,498	61,468,034	(67,271,744)	(5,764,212)
Balance at the beginning of the year (in Shares) at Dec. 31, 2019	39,497,480
Common stock issued for acquisition of SevenFive Farms	$ 8,859	1,894,522		1,903,381
Common stock issued for acquisition of SevenFive Farms (in shares)	8,859,117
Common stock issued upon conversion of debt	$ 2,215	954,841		957,056
Common stock issued upon conversion of debt (in shares)	2,215,892
Stock options granted to employees and consultants		926,698		926,698
Cashless exercise of warrants	$ 374	821,164		821,538
Cashless exercise of warrants (in shares)	373,340
Sale of common stock, net of issuance costs	$ 43	99,957		100,000
Sale of common stock, net of issuance costs (in shares)	42,735
Beneficial conversion feature		233,500		233,500
Warrants exercised	$ 200	172,041		172,241
Warrants exercised (in shares)	200,000
Warrants issued with the 15% Notes		835,499		835,499
Net loss			(3,955,086)	(3,955,086)
Balance at the end of the year at Jun. 30, 2020	$ 51,189	67,406,256	(71,226,830)	(3,769,385)
Balance at the end of the year(in Shares) at Jun. 30, 2020	51,188,564
Balance at the beginning of the year at Mar. 31, 2020	$ 40,282	63,550,821	(69,285,923)	(5,694,820)
Balance at the beginning of the year (in Shares) at Mar. 31, 2020	40,281,881
Common stock issued for acquisition of SevenFive Farms	$ 8,859	1,894,522		1,903,381
Common stock issued for acquisition of SevenFive Farms (in shares)	8,859,117
Common stock issued upon conversion of debt	$ 1,674	705,382		707,056
Common stock issued upon conversion of debt (in shares)	1,674,226
Stock options granted to employees and consultants		434,367		434,367
Cashless exercise of warrants	$ 374	821,164		821,538
Cashless exercise of warrants (in shares)	373,340
Net loss			(1,940,907)	(1,940,907)
Balance at the end of the year at Jun. 30, 2020	$ 51,189	$ 67,406,256	$ (71,226,830)	$ (3,769,385)
Balance at the end of the year(in Shares) at Jun. 30, 2020	51,188,564